vs
礼来（RNA）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是TRANSACT TECHNOLOGIES INC的1.1倍（$12.5M vs $11.5M），礼来同比增速更快（434.0% vs 11.9%），TRANSACT TECHNOLOGIES INC自由现金流更多（$589.0K vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs 3.5%）
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
RNA vs TACT — 直观对比
营收规模更大
RNA
是对方的1.1倍
$11.5M
营收增速更快
RNA
高出422.1%
11.9%
自由现金流更多
TACT
多$157.5M
$-156.9M
两年增速更快
RNA
近两年复合增速
3.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.5M | $11.5M |
| 净利润 | $-174.4M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | -1513.5% | -10.1% |
| 净利率 | -1398.3% | — |
| 营收同比 | 434.0% | 11.9% |
| 净利润同比 | -117.0% | — |
| 每股收益（稀释后） | $-1.27 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RNATACT
| Q4 25 | — | $11.5M | ||
| Q3 25 | $12.5M | $13.2M | ||
| Q2 25 | $3.8M | $13.8M | ||
| Q1 25 | $1.6M | $13.1M | ||
| Q4 24 | $3.0M | $10.2M | ||
| Q3 24 | $2.3M | $10.9M | ||
| Q2 24 | $2.0M | $11.6M | ||
| Q1 24 | $3.5M | $10.7M |
净利润RNATACT
| Q4 25 | — | — | ||
| Q3 25 | $-174.4M | $15.0K | ||
| Q2 25 | $-157.3M | $-143.0K | ||
| Q1 25 | $-115.8M | $19.0K | ||
| Q4 24 | $-102.3M | — | ||
| Q3 24 | $-80.4M | $-551.0K | ||
| Q2 24 | $-70.8M | $-319.0K | ||
| Q1 24 | $-68.9M | $-1.0M |
毛利率RNATACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率RNATACT
| Q4 25 | — | -10.1% | ||
| Q3 25 | -1513.5% | 0.1% | ||
| Q2 25 | -4448.7% | -1.9% | ||
| Q1 25 | -8360.9% | -0.1% | ||
| Q4 24 | -4069.6% | -10.3% | ||
| Q3 24 | -4200.9% | -7.7% | ||
| Q2 24 | -4040.4% | -3.8% | ||
| Q1 24 | -2178.6% | -12.2% |
净利率RNATACT
| Q4 25 | — | — | ||
| Q3 25 | -1398.3% | 0.1% | ||
| Q2 25 | -4089.3% | -1.0% | ||
| Q1 25 | -7360.0% | 0.1% | ||
| Q4 24 | -3439.5% | — | ||
| Q3 24 | -3441.7% | -5.1% | ||
| Q2 24 | -3461.8% | -2.8% | ||
| Q1 24 | -1943.4% | -9.7% |
每股收益（稀释后）RNATACT
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-1.27 | $0.00 | ||
| Q2 25 | $-1.21 | $-0.01 | ||
| Q1 25 | $-0.90 | $0.00 | ||
| Q4 24 | $-0.80 | $-0.80 | ||
| Q3 24 | $-0.65 | $-0.06 | ||
| Q2 24 | $-0.65 | $-0.03 | ||
| Q1 24 | $-0.79 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $350.2M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $31.1M |
| 总资产 | $2.1B | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RNATACT
| Q4 25 | — | $20.4M | ||
| Q3 25 | $350.2M | $20.0M | ||
| Q2 25 | $243.9M | $17.7M | ||
| Q1 25 | $254.2M | $14.2M | ||
| Q4 24 | $219.9M | $14.4M | ||
| Q3 24 | $370.2M | $11.3M | ||
| Q2 24 | $575.8M | $11.1M | ||
| Q1 24 | $471.4M | $10.6M |
股东权益RNATACT
| Q4 25 | — | $31.1M | ||
| Q3 25 | $1.9B | $31.8M | ||
| Q2 25 | $1.2B | $31.3M | ||
| Q1 25 | $1.3B | $30.9M | ||
| Q4 24 | $1.4B | $30.6M | ||
| Q3 24 | $1.5B | $38.4M | ||
| Q2 24 | $1.2B | $38.5M | ||
| Q1 24 | $830.9M | $38.6M |
总资产RNATACT
| Q4 25 | — | $44.8M | ||
| Q3 25 | $2.1B | $45.0M | ||
| Q2 25 | $1.4B | $44.5M | ||
| Q1 25 | $1.5B | $44.2M | ||
| Q4 24 | $1.6B | $44.0M | ||
| Q3 24 | $1.6B | $50.5M | ||
| Q2 24 | $1.3B | $50.4M | ||
| Q1 24 | $951.5M | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-156.2M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | $-156.9M | $589.0K |
| 自由现金流率自由现金流/营收 | -1257.6% | 5.1% |
| 资本支出强度资本支出/营收 | 5.7% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-592.3M | $7.6M |
8季度趋势，按日历期对齐
经营现金流RNATACT
| Q4 25 | — | $609.0K | ||
| Q3 25 | $-156.2M | $3.6M | ||
| Q2 25 | $-199.7M | $3.6M | ||
| Q1 25 | $-124.8M | $-161.0K | ||
| Q4 24 | $-99.9M | $2.4M | ||
| Q3 24 | $-65.6M | $327.0K | ||
| Q2 24 | $-65.0M | $636.0K | ||
| Q1 24 | $-70.4M | $-1.5M |
自由现金流RNATACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | $-156.9M | $3.6M | ||
| Q2 25 | $-203.0M | $3.6M | ||
| Q1 25 | $-128.6M | $-171.0K | ||
| Q4 24 | $-103.8M | $2.4M | ||
| Q3 24 | $-67.3M | $259.0K | ||
| Q2 24 | $-65.5M | $499.0K | ||
| Q1 24 | $-71.3M | $-1.6M |
自由现金流率RNATACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | -1257.6% | 27.1% | ||
| Q2 25 | -5277.1% | 25.9% | ||
| Q1 25 | -8174.3% | -1.3% | ||
| Q4 24 | -3491.0% | 23.2% | ||
| Q3 24 | -2881.8% | 2.4% | ||
| Q2 24 | -3204.6% | 4.3% | ||
| Q1 24 | -2012.3% | -14.9% |
资本支出强度RNATACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | 5.7% | 0.5% | ||
| Q2 25 | 86.9% | 0.1% | ||
| Q1 25 | 238.6% | 0.1% | ||
| Q4 24 | 131.7% | 0.1% | ||
| Q3 24 | 72.9% | 0.6% | ||
| Q2 24 | 26.0% | 1.2% | ||
| Q1 24 | 25.8% | 1.0% |
现金转化率RNATACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
